Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre

被引:19
作者
Graham, Janet
Hiremath, Swapnil
Magner, Peter O.
Knoll, Greg A.
Burns, Kevin D. [1 ]
机构
[1] Ottawa Hosp, Dept Med, Div Nephrol, Ottawa, ON K1H 7W9, Canada
关键词
arteriovenous fistula; central venous catheters; haemodialysis; vascular access;
D O I
10.1093/ndt/gfn317
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. The arteriovenous (AV) fistula is the optimal vascular access for chronic haemodialysis (HD) patients. The Dialysis Outcomes and Practice Patterns Study (DOPPS II) reported a high use of central venous (CV) catheters for HD in Canadian centres. We studied factors influencing the choice of access in a prevalent HD population at a Canadian centre. Methods. This was a cross-sectional study of all HD patients at the Ottawa Hospital (Ottawa, Canada). Demographic information, the type of HD vascular access used and the factors influencing access choice were obtained from medical records. Nephrologists at the Ottawa Hospital were surveyed to identify attitudes that might influence the choice of HD access. Results. In the survey of nephrologists (n = 17), there was 100% agreement that the AV fistula is the optimal HD access. In 599 prevalent chronic HD patients, AV fistulae were used in 58.0% (n = 347), CV catheters in 39.7% (n = 238) and only 2.3% had AV grafts (n = 14). By multivariate logistic regression, female gender, peripheral vascular disease and shorter duration of HD were independent predictors of CV catheter use. Of the patients with CV catheters, 68.9% had vascular factors or medical contraindications that precluded AV fistula creation. System/resource limitations influenced choice of access in only 19.3% of patients with CV catheters, although these factors were more important in patients within the first 6 months of HD initiation. Conclusions. The relatively high prevalence of CV catheter use at our HD centre is due mainly to patient-specific factors (e.g. unsuitable vessels or medical co-morbidities), rather than resource limitations or physician attitudes. Target setting for AV fistula use requires consideration of these factors as well as the effect of HD duration.
引用
收藏
页码:3585 / 3591
页数:7
相关论文
共 19 条
  • [1] Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO Study
    Allon, M
    Ornt, DB
    Schwab, SJ
    Rasmussen, C
    Delmez, JA
    Greene, T
    Kusek, JW
    Martin, AA
    Minda, S
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (05) : 2178 - 2185
  • [2] Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study
    Allon, M
    Depner, TA
    Radeva, M
    Bailey, J
    Beddhu, S
    Butterly, D
    Coyne, DW
    Gassman, JJ
    Kaufman, AM
    Kaysen, GA
    Lewis, JA
    Schwab, SJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : 1863 - 1870
  • [3] Type of vascular access and survival among incident hemodialysis patients: The choices for healthy outcomes in caring for ESRD (CHOICE) study
    Astor, BC
    Eustace, JA
    Powe, NR
    Klag, MJ
    Fink, NE
    Coresh, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05): : 1449 - 1455
  • [4] CANADIAN HEMODIALYSIS MORBIDITY STUDY
    CHURCHILL, DN
    TAYLOR, DW
    COOK, RJ
    LAPLANTE, P
    BARRE, P
    CARTIER, P
    FAY, WP
    GOLDSTEIN, MB
    JINDAL, K
    MANDIN, H
    MCKENZIE, JK
    MUIRHEAD, N
    PARFREY, PS
    POSEN, GA
    SLAUGHTER, D
    ULAN, RA
    WERB, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) : 214 - 234
  • [5] Type of vascular access and mortality in US hemodialysis patients
    Dhingra, RK
    Young, EW
    Hulbert-Shearon, TE
    Leavey, SF
    Port, FK
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (04) : 1443 - 1451
  • [6] The effect of patient age and other factors on the maintenance of permanent hemodialysis vascular access
    Hayakawa, Kunihiro
    Miyakawa, Shinzaburo
    Hoshinaga, Kiyotaka
    Hata, Kenichi
    Marumo, Ken
    Hata, Makoto
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (01) : 36 - 41
  • [7] Hirth RA, 1996, JAMA-J AM MED ASSOC, V276, P1303
  • [8] Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1
  • [9] Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II)
    Mendelssohn, DC
    Ethier, J
    Elder, SJ
    Saran, R
    Port, FK
    Pisoni, RL
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (03) : 721 - 728
  • [10] *NKF K DOQI VASC A, 2006, AM J KIDNEY DIS S, V48, pS243